We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+28.85%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$117M
AUM Growth
+$5.01M
Cap. Flow
-$4.67M
Cap. Flow %
-3.97%
Top 10 Hldgs %
39.15%
Holding
85
New
22
Increased
25
Reduced
13
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.7M
2
INCY icon
Incyte
INCY
+$2.45M
3
SCTY
SolarCity Corporation
SCTY
+$2.25M
4
INSY
Insys Therapeutics, Inc.
INSY
+$1.98M
5
LVS icon
Las Vegas Sands
LVS
+$1.97M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.91M
2
TCS
THE CONTAINER STORE GROUP, INC.
TCS
+$3M
3
MEG
Media General, Inc
MEG
+$2.88M
4
GENT
GENTIUM SPA ADS
GENT
+$2.63M
5
LNKD
LinkedIn Corporation
LNKD
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 36.91%
2 Industrials 12.76%
3 Communication Services 12.13%
4 Technology 6.3%
5 Materials 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHTH icon
1
eHealth
EHTH
$42.5M
$6.22M 5.3%
122,500
+31,750
+35% +$1.65M
IBB icon
2
PUT
iShares Biotechnology ETF
IBB
$9.31B
$6.17M 5.25%
+78,300
New +$6.52M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.9T
$5.41M 4.6%
194,727
+36,135
+23% +$1.05M
DOOR
4
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$4.69M 3.99%
82,975
-6,725
-7% -$380K
EXP icon
5
Eagle Materials
EXP
$6.6B
$4.61M 3.92%
52,000
+15,000
+41% +$1.24M
ICPT
6
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4.48M 3.81%
13,580
-5,420
-29% -$1.83M
ACAD icon
7
Acadia Pharmaceuticals
ACAD
$4.25B
$4.37M 3.72%
179,700
+4,725
+3% +$120K
INCY icon
8
Incyte
INCY
$23.5B
$3.61M 3.08%
67,500
+39,500
+141% +$2.45M
TW
9
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$3.47M 2.96%
30,450
-6,550
-18% -$763K
META icon
10
Meta Platforms (Facebook)
META
$1.51T
$2.96M 2.52%
49,100
+3,350
+7% +$212K
TMO icon
11
Thermo Fisher Scientific
TMO
$211B
$2.83M 2.41%
23,500
+8,000
+52% +$951K
SPLK
12
DELISTED
Splunk Inc
SPLK
$2.7M 2.3%
37,770
+7,770
+26% +$634K
ILMN icon
13
Illumina
ILMN
$29.4B
$2.6M 2.21%
17,990
-9,740
-35% -$1.43M
BIIB icon
14
Biogen
BIIB
$29.9B
$2.6M 2.21%
+8,500
New +$2.7M
SCTY
15
DELISTED
SolarCity Corporation
SCTY
$2.57M 2.19%
41,000
+31,125
+315% +$2.25M
PCRX icon
16
Pacira BioSciences
PCRX
$1.02B
$2.45M 2.09%
35,000
+12,000
+52% +$816K
ENDP
17
DELISTED
Endo International plc
ENDP
$2.37M 2.01%
34,480
+4,330
+14% +$307K
CSTE icon
18
Caesarstone
CSTE
$72.3M
$2.26M 1.92%
41,500
+11,400
+38% +$601K
OCR
19
DELISTED
OMNICARE INC
OCR
$2.21M 1.88%
37,000
-28,000
-43% -$1.7M
PRTA icon
20
Prothena Corp
PRTA
$458M
$2.2M 1.88%
57,500
+20,000
+53% +$645K
YELP icon
21
Yelp
YELP
$1.38B
$2.12M 1.8%
27,500
+5,650
+26% +$477K
INSY
22
DELISTED
Insys Therapeutics, Inc.
INSY
$2.06M 1.76%
+99,624
New +$1.98M
WAGE
23
DELISTED
WageWorks, Inc.
WAGE
$2M 1.7%
35,700
-12,300
-26% -$742K
LVS icon
24
Las Vegas Sands
LVS
$30.5B
$1.98M 1.68%
+24,500
New +$1.97M
MLM icon
25
Martin Marietta Materials
MLM
$33.6B
$1.93M 1.64%
+15,000
New +$1.72M
1
2 3 4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ATS
Ashton Thomas Securities Rochester, New York $797M AUM 18.33% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return

Atika Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Atika Capital Management held 85 positions worth $117M, up 4.5% from $112M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $4.67M in Q1 2014, closing 24 positions and reducing 13 holdings. Its most notable exit was Gilead Sciences, an estimated $3.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 28% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Atika Capital Management opened a new position in Biogen worth $2.6M.

  • Atika Capital Management's largest Q1 2014 buy was Biogen: 8,500 shares worth $2.6M.
  • Atika Capital Management added most to Incyte in Q1 2014, an estimated $2.45M increase.
  • Atika Capital Management's biggest Q1 2014 reduction was Netflix, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Gilead Sciences in Q1 2014, selling an estimated $3.91M.
  • Atika Capital Management's ten largest holdings make up 39% of its $117M portfolio in Q1 2014.
  • Atika Capital Management opened 22 new positions and closed 24 in Q1 2014.
  • Atika Capital Management's portfolio value rose 4.5% quarter-over-quarter to $117M.

Based on Atika Capital Management's 13F filing for Q1 2014, filed 15 May 2014.